MiR-365 suppresses cholangiocarcinoma cell proliferation and induces apoptosis by targeting E2F2.
Cholangiocarcinoma (CCA) is one of the most malignant adenocarcinoma arising from bile duct epithelial cells. However,the molecular mechanism regulating CCA development and progression requires to be investigated. Here, we found that miR-365 was downregulated in CCA tissues compared with adjacent normal tissues. By functional experiments, we found that overexpression of miR-365 significantly inhibited CCA cell proliferation and promoted cellular apoptosis in vitro. Furthermore, administration with miR-365 markedly suppressed the growth of tumor tissues in vivo. Mechanistically, we identified E2F2 was the target gene of miR-365 in CCA cells. We found that overexpression significantly inhibited the expression of E2F2 in CCA cells. And there was an inversely correlation between the expression levels of E2F2 and miR-365 in CCAtissues. What's more, we found that E2F2 was highly expressed in CCA tissues and cell lines. And restoration of E2F2 in miR-365-overexpressing CCA cells promoted cell viability and reduced cellular apoptosis in CCA. Collectively, our study demonstrated the essential role of miR-365 and its functional mechanism in CCA cells, which provided a new insight on the design of therapeutic targets for CCA treatment.